About The Medical Condition Drug Evaluation, FDA Phase II

ClusterMed

Find the definition of the medical term Drug Evaluation, FDA Phase II. Drug Evaluation, FDA Phase II defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.

Drug Evaluation, FDA Phase II

Drug Evaluation, FDA Phase II Medical Condition Defined & Explained
Drug Evaluation, FDA Phase II Medical Condition

What's The Definition Of The Medical Condition Drug Evaluation, FDA Phase II?

Studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries.

More Medical Conditions

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Medical Conditions Definitions Of The Day